ArticleJournal of cellular and molecular medicine2026

Qiliqiangxin Improves Cardiac Glucose Metabolism After Myocardial Infarction Through a HIF-1α/MIF/AMPK Axis.

Zimu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.